tradingkey.logo

Fresenius Medical Care AG

FMS
View Detailed Chart

24.731USD

-0.239-0.96%
Market hours ETQuotes delayed by 15 min
7.26BMarket Cap
10.08P/E TTM

Fresenius Medical Care AG

24.731

-0.239-0.96%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.96%

5 Days

-0.16%

1 Month

-0.56%

6 Months

+2.83%

Year to Date

+9.24%

1 Year

+17.26%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
50 / 72
Overall Ranking
260 / 4724
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Hold
Current Rating
28.351
Target Price
+13.54%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 20.53, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.25M shares, decreasing 4.25% quarter-over-quarter.
Held by Richard Pzena
Star Investor Richard Pzena holds 14.66M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Ticker SymbolFMS
CompanyFresenius Medical Care AG
CEODr. Katarzyna Mazur-Hofsaess
Websitehttps://www.freseniusmedicalcare.com/
KeyAI